371 results on '"Mayerle, Julia"'
Search Results
2. Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?
3. Metabolomic Analysis of Human Cirrhosis and Hepatocellular Carcinoma: A Pilot Study
4. Entzündliche Lebererkrankungen
5. Mechanisms in Systemic Inflammation
6. Intensivtherapie bei akuter Pankreatitis
7. Pankreaskarzinom – Screening oder Surveillance: Was ergibt Sinn?
8. Pankreaszysten – Indikationen, Zeitpunkt und Rationale für eine Surveillance
9. Pankreaskarzinom – Screening oder Surveillance?
10. Validation of the SACOV-19 score for identifying patients at risk of complicated or more severe COVID-19: a prospective study
11. Substantial differences in perception of disease severity between post COVID-19 patients, internists, and psychiatrists or psychologists: the Health Perception Gap and its clinical implications
12. Akute Pankreatitis - Diagnose und Management
13. Severity and outcome of a first episode of idiopathic acute pancreatitis is not more severe than pancreatitis of other etiologies
14. A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich
15. Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study
16. Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events
17. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment
18. How to exclude pulmonary embolism in patients hospitalized with COVID-19: a comparison of predictive scores
19. Investigation of the Interplay between Circulating Lipids and IGF-I and Relevance to Breast Cancer Risk: An Observational and Mendelian Randomization Study
20. Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board
21. Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based study
22. An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targets
23. Intensivtherapie bei akuter Pankreatitis
24. Pankreaszysten – Indikationen, Zeitpunkt und Rationale für eine Surveillance
25. Pankreaskarzinom – Screening oder Surveillance: Was ergibt Sinn?
26. Genetic Testing in Acute and Chronic Pancreatitis
27. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment
28. CRISPR somatic genome engineering and cancer modeling in the mouse pancreas and liver
29. Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning
30. Impact of tumor size and location on endoscopic ultrasound-guided sampling of pancreatic neuroendocrine tumors: A recursive partitioning analysis
31. HLA-DRB1∗16 and -DQB1∗05 alleles are strongly associated with autoimmune pancreatitis in a cohort of hundred patients
32. In mouse chronic pancreatitis CD25+FOXP3+ regulatory T cells control pancreatic fibrosis by suppression of the type 2 immune response
33. Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarcinoma: a systematic review
34. p70 Ribosomal Protein S6 Kinase Is a Checkpoint of Human Hepatic Stellate Cell Activation and Liver Fibrosis in Mice
35. Early infection is an independent risk factor for increased mortality in patients with culture-confirmed infected pancreatic necrosis
36. Severity of Gallstone-, Sludge-, or Microlithiasis-Induced Pancreatitis--All of the Same?
37. Electronic data capture in resource-limited settings using the lightweight clinical data acquisition and recording system.
38. Einfluss der Spezialisierung auf primäre Erfolgs- sowie Komplikationsrate bei der ERCP. Vorschlag zur Verbesserung der Qualität der ERCP.
39. Konservative oder chirurgische Therapie der chronischen Pankreatitis?
40. Lipaseerhöhung
41. Clinical and translational markers of severity and prognosis in chronic pancreatitis
42. Sequential or up-front triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma (HCC): MONTBLANC.
43. Abstract A055: Context-dependent role of acid sphingomyelinase in pancreatic ductal adenocarcinoma
44. Altered histone acetylation patterns in pancreatic cancer cell lines induce subtype‑specific transcriptomic and phenotypical changes
45. The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4-/- Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell Pathophysiology
46. Prognoseverbesserung durch Screening- und Surveillance-Strategien für Leber- und Pankreaserkrankungen
47. Expression of Irf3 and Irf7 in tumour cells drives pancreatic cancer development and progression
48. Biological role of acid sphingomyelinase for pancreatic carcinogenesis
49. Acute pancreatitis - diagnosis and management
50. Influence of cancer associated fibroblasts (CAFs) heterogeneity on shaping immunosuppressive tumour microenvironment in PDAC
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.